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OBJECTIVES: This study sought to verify the effects of acupuncture as an adjuvant treatment for the control of
asthma.
METHODS: This was a randomized, controlled, crossover trial conducted at the Hospital das Clı´nicas da Faculdade de
Medicina da Universidade de Sa˜o Paulo. A total of 74 patients withmild/moderate, persistent asthmawere randomized
into two therapeutic groups: Group A – 31 patients underwent 10 real weekly acupuncture sessions, followed by a
3-week washout period and 10 sham weekly acupuncture sessions; and Group B - 43 patients underwent 10 sham
weekly acupuncture sessions, followed by a 3-week washout period and 10 real weekly acupuncture sessions. Patients
used short- and long-acting b-2 agonists and inhaled corticosteroids when necessary. Prior to treatment and after each
period of 10 treatment sessions, the patients were evaluated for spirometry, induced sputum cell count, exhaled nitric
oxide (NO) and with the Short Form 36 (SF-36) and Questionnaire on Quality of Life-Asthma (QQLA) questionnaires.
Daily peak flow and symptom diaries were registered. The level of significance adopted was 5% (a=0.05).
RESULTS: In Group B, after real acupuncture, there was a decrease in eosinophils (p=0.035) and neutrophils (p=0.047),
an increase in macrophages (p=0.001) and an improvement in peak flow (p=0.01). After sham acupuncture treatment,
patients experienced less coughing (p=0.037), wheezing (p=0.013) and dyspnea (p=0.014); similarly, after real
acupuncture, patients reported less coughing (p=0.040), wheezing (p=0.012), dyspnea (po0.001) and nocturnal
awakening episodes (p=0.009). In Group A, there was less use of rescue medication (p=0.043). After the sham
procedure, patients in Group A experienced less coughing (p=0.007), wheezing (p=0.037), dyspnea (po0.001) and use
of rescuemedication (po0.001) and after real acupuncture, these patients showed improvements in functional capacity
(p=0.004), physical aspects (p=0.002), general health status (po0.001) and vitality (p=0.019). Sham acupuncture also led
to significant differences in symptoms, but these were not different from those seen with real acupuncture. Spirometry
and exhaled NO levels did not show a difference between sham and real acupuncture treatment. In addition, no
significant difference was demonstrated between treatments regarding the quality of life evaluation.
CONCLUSION: Real and sham acupuncture have different effects and outcomes on asthma control. The crossover
approach was not effective in this study because both interventions led to improvement of asthma symptoms, quality
of life and inflammatory cell counts. Thus, sham acupuncture cannot serve as a placebo in trials with acupuncture as
the main intervention for asthma.
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’ INTRODUCTION
Asthma is a chronic condition with a global incidence that
has progressively increased in recent decades (1). It is
estimated that approximately 300 million people are cur-
rently affected by asthma (1). Asthma is defined as aDOI: 10.6061/clinics/2015(10)01
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condition that causes chronic inflammation in the airways,
leading to a state of hyper-responsiveness and resulting in
bronchospasm, an increase in mucus production and
limitation to air flow (1). The most common symptoms of
asthma are wheezing, coughing, chest tightness and dys-
pnea. Pharmacological treatment includes short-acting and
some long-acting b-2 agonists, glucocorticoids (both oral and
inhaled), a leukotriene modifier and theophylline, among
others (1). Although medications and updated approaches
have been effective tools for controlling asthma, many other
approaches have been studied to help asthmatic patients
reach both symptom control and improvement in their
quality of life, particularly non-conventional healing techni-
ques (2-4). Among these non-conventional approaches,
termed alternative/complementary medicine, acupuncture
has become one of the most popular techniques used to
control asthma (5).
Acupuncture is one of several traditional Chinese medi-
cine therapeutic methods. For thousands of years, acupunc-
ture has been used to treat several conditions, including
asthma (6). In comparison to mainstream medicine, acu-
puncture is considered a complementary/alternative healing
technique and has been considered to be effective for
conditions such as nausea and emesis post-chemotherapy,
dental pain, osteoarthritis pain and headache, among others
(7). The apparent lack of significant adverse effects, unlike
those experienced with the use of glucocorticoids and the
possible effects linked to the release of adrenocorticotropic
hormone (ACTH) and endogenous corticoids, supports the
use of acupuncture for the treatment of asthma. Several
studies have been conducted to investigate acupuncture in
the treatment of asthma, with controversial results (6,8-10).
Most previous studies favoring acupuncture for the treat-
ment of asthma have been published in non-English
language journals and they lack good epidemiological
design (10). Indeed, there are some inherent difficulties in
designing and establishing placebo controls in studies
involving acupuncture (11,12). Due to the nature of hetero-
dox methods of diagnosis, some diseases or conditions can
be understood as having different etiologic agents, diverse
pathophysiologic mechanisms and different methods of
treatment. Thus, more studies about the effect of acupuncture
in asthma are needed.
To better study and perhaps understand the possible
effects of acupuncture in mild and moderate asthma, we
designed and performed the present study in the Clinics
Hospital of the University of São Paulo School of Medicine,
one of the largest medical centers in Latin America, using the
following primary end-points: symptomatic and quality of
life improvement, spirometry and peak flow improvement
and inflammatory improvement (cell counting and nitric
oxide (NO) measurements).
Strengths and limitations of this study
This study attempted to evaluate the effects of acupunc-
ture on patients with asthma in a controlled, randomized,
double-blind crossover trial and it may have shown the
positive effects of acupuncture for the following end-points:
1) Symptom control
2) Cell counts in induced sputum
3) Peak flow
4) Quality of life
However, there are several limitations of the study:
1) A significant number of patients quit the study prior to
completion
2) No significant difference was demonstrated between the
sham and real acupuncture treatments regarding the
quality of life evaluation
’ MATERIAL AND METHODS
This was a double-blind (patient and clinicians), randomized,
crossover clinical trial study where all enrolled patients
underwent both sham and real acupuncture. A specific
calculation for sample size was not performed because there
was no defined effect to reach with the qualitative variables
(quality of life evaluation, symptoms, etc.). We recruited
patients through the written press and performed the first
interview by phone to evaluate the general conditions needed
for enrollment in the study. After the first interview, the patients
were taught how to answer a daily symptom scale, perform
peak flow measurements and answer quality of life question-
naires, including the Short Form 36 (SF-36) and Questionnaire
on Quality of Life-Asthma (QQLA). Afterwards, a second
interview was conducted and the volunteers were invited by
research staff to participate in the project.
The quality of life questionnaires were completed initially,
before beginning the treatment procedure and also after each
treatment period (sham and real acupuncture). Hence, each
patient answered both the questionnaires three times. These
questionnaires are useful instruments for measuring quality of
life in respiratory-impaired patients. Some of the questions were
particularly useful, such as those regarding physical limitations,
functional capacity and the frequency and severity of symptoms.
A total 184 patients were included according to the
following criteria: non-smokers; forced expiratory volume of
first second (FEV1) X 70% and peak flow variability p 20%;
asthma symptoms at least twice per week and a maximum
5 times per week; nocturnal awakening o 4 times per month;
use of relieving inhaled b-2 rapid-acting/long-acting or inhaled
glucocorticoids; and lack of other cardiovascular disease or
chronic obstructive pulmonary disease (COPD).
Patients interested in participating but not enrolled to this
study were excluded according to the following criteria:
participating in another clinical trial; co-morbidity with other
lung or systemic disease; past bleeding or coagulopathy;
recent asthma exacerbation by upper airway infection; use of
antidepressant medication; pregnancy; smoker or ex-smoker
who quit less than 1 year ago; or drug addict.
The enrolled patients were allocated randomly, using a
simple random sampling method, to 2 groups and had their
spirometry, sputum cell count, NO measurement and
medical interview performed before they began the treat-
ment. During this period of inclusion, the patients were
taught how to perform daily peak flow measurements and
how to complete daily symptom scales. Subsequently, they
were randomly allocated into one of two treatment groups:
1) Group A, in which patients first received real acupuncture
for 10 weekly sessions and 2) Group B, in which patients first
received sham acupuncture treatment with points not related
to the treatment of asthma in traditional Chinese medicine
(some are not described as acupoints) for 10 weekly sessions.
After 10 sessions, the patients in both groups underwent
spirometry and induced sputum cells counts and NO
measurements were again performed. Both groups underwent
664
Crossover acupuncture clinical trial on asthma
Pai HJ et al.
CLINICS 2015;70(10):663-669
a 3-week washout period and then performed the crossover
process, in which Group A and Group B exchanged the form of
needling, with Group A receiving sham point needling and
Group B receiving real acupoint needling. After 10 weekly
sessions, new objective measurements were performed. During
each study period, patients suffering an asthma exacerbation
were rescued with b-agonists (both short-and long-acting) and
inhaled glucocorticoids. During the period of treatment, 36
patients used short-acting b-2 agonists as rescue medications, 6
patients used inhaled corticosteroids, 49 patients used a
combination of short-acting b-2 and long-acting b-2 agonists
with inhaled corticosteroids, 3 patients used b-2 short-acting
agonists with inhaled corticosteroids and a leukotriene modifier
and 2 used theophylline and a short-acting b-2 agonist. The
procedure is summarized in Figure 1.
The patients were randomly allocated; there was only one
physician who performed acupuncture on the patients.
Neither the patient, nor the interviewer, nor the technician
who measured the induced sputum cell counts, NO
measurements and spirometry had knowledge of the type
of acupuncture (real or sham) the patients were undergoing.
In the end, a total of 74 patients achieved a total of
20 sessions of treatment, comprising 10 with real acupunc-
ture and 10 with sham acupuncture.
All of the patients underwent their laboratory exams in the
Clinics Hospital of the University of São Paulo Faculty of
Medicine and underwent the sessions of treatment in a
location specifically prepared to perform this study.
The local Committee for Ethical Issues in Human Research
approved this study.
Statistical analysis
The quantitative continuous variables were analyzed
using the student’s t test for two independent samples or
by paired t test, as appropriate.
The ordinal qualitative variables were analyzed using the
Mann-Whitney test for two independent samples or by
Wilcoxon test for two paired samples.
The nominal qualitative variables were analyzed using the
Chi-Squared test or Fisher Exact test, as appropriate.
We adopted a statistical significance level of 5% (a=0.05).
The analyses were performed using Minitab 15.0 and SPSS
16.0 for Windows.
Figure 1 - Protocol fluxogram showing how patients enrolled in the study were divided and treated.
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’ RESULTS
From January 2003 to December 2007, a total 185
volunteers were recruited. Of these, only 74 completed the
study by passing through both the sham and real acupunc-
ture treatment groups. Forty-three volunteers began with the
sham technique (Group B), passed through the washout
period and subsequently received real acupuncture treat-
ment. Thirty-one subjects were allocated to the group that
first received real acupuncture (Group A) and after a
washout period, the subjects passed to the sham acupuncture
treatment.
The groups of volunteers comprised 52 females (70%) and
22 males (30%), with a mean age of 32.5 years for Group A
(acupuncture as the first procedure) and 37.4 years for
Group B (sham as the first procedure). Because this was a
very long-term trial, we had a considerable loss of patients.
A total 111 volunteers quit the trial for several reasons such
as job overload, moving from former addresses, asthma
symptoms brought under control during the trial and other
concurrent diseases occurring while undergoing the trial. We
also had problems with volunteers not filling out the
proposed questionnaires, making it impossible to use these
questionnaires for evaluation.
No patients reported any harm or adverse effects during
the period of intervention.
Peak flow
There was a significant increase in peak flow measure-
ments in Group B patients after the real acupuncture
intervention (Table 1).
Cell counts in induced sputum analysis
There was a significant decrease in the eosinophil and
neutrophil counts and a significant increase in the macro-
phage count in the induced sputum in Group B subjects after
the real acupuncture procedure (Table 2).
Self-report of daily symptoms scale
In terms of daily symptoms related to asthma, there was a
significant decrease among Group A subjects regarding the
b-2 agonists required, comparing the inclusion period to the
period after the real acupuncture procedure. In addition,
there was a significant decrease in coughing, wheezing,
dyspnea and b-2 agonist spray use, comparing the inclusion
period to that after the sham procedure (Table 3).
In Group B, there was also a significant decrease in
coughing, wheezing, and dyspnea, comparing the inclusion
period to that after the sham procedure. Comparing the
inclusion period to that following real acupuncture treatment,
there was also a significant decrease in coughing, wheezing,
dyspnea and nocturnal awakening (Table 3).
Quality of life evaluation
A- Questionnaire on Quality of Life-Asthma, Universidade
Federal de Sa˜o Paulo, Escola de Medicina (QQLA). The
results showed improvement in some domains of the QQLA
and this improvement was observed after both the real
acupuncture and after the sham procedure. However, after
the real acupuncture, more domains showed improvement
than after the sham procedure. In this questionnaire, patients
experienced improvement in domains such as physical
limitation, socio-economic aspects, symptom frequency and
severity, adherence to treatment and social and psychological
aspects (Table 4). However, there was no significant difference
between the real acupuncture and the sham procedure
treatments.
SF-36 medical outcome study
As described above for the QQLA, we found a very similar
result for the SF-36. Both the sham and real acupuncture
treatments seemed to improve domains related to functional
capacity, physical aspects, general health status, mental
health, social aspects and vitality (Table 5). However, there
was no difference in this improvement when comparing
sham and real acupuncture.
We also found no difference comparing the inclusion
period to both the sham and real acupuncture periods for
other measurements such as spirometry and NO exhaled
measurements.
’ DISCUSSION
For thousands of years, acupuncture has been used as a
first-choice treatment for several illnesses on the Asian
continent, mostly in countries such as China, Japan and
Korea, as well as in Southeast Asia (6). Although the efficacy
of acupuncture remains unknown (because of a lack of
reliable case records from the distant past), most traditional
Chinese medicine practitioners claim that acupuncture is
effective in asthma symptom control (10).
This study was conducted to test the consistency of the
positive effect of acupuncture in asthma control. We decided
not only to study symptom control but also to determine
whether acupuncture has some influence on small airway
inflammation; thus, we collected data on spirometry, total
cell counts in induced sputum and NO measurements. We
also collected data on daily symptom scales and measured
quality of life through two pertinent questionnaires.
The design of our study was a crossover type, to facilitate
recruitment by not having to recruit separate control,
sham (placebo) and real acupuncture groups (treatment
group). The aim was that during the enrolling period, once
we had collected the measurements for spirometry, the
symptom scale, quality of life questionnaire, total cell counts
in induced sputum and NO, the patients would be
considered a control group. Afterwards, while each one of
the patients passed throughout the different stages of
treatment, they would be delegated to a placebo (sham)
group or a treatment (acupuncture) group. This type of
design was quite risky because we could not find another
similar study to establish an acceptable period of washout for
the acupuncture effect. We decided to extend the well-validated
Table 1 - Peak flow measurements compared with baseline after
real acupuncture in Group B.
Peak Flow (L/minute)
Mean Standard
Deviation
Standard Error
of Mean
Before any intervention 324.3 95.0 15.6
Real Acupuncture 345.8 92.4 15.2
Differences -21.51 48.42 7.96
p=0.010
666
Crossover acupuncture clinical trial on asthma
Pai HJ et al.
CLINICS 2015;70(10):663-669
washout period of two weeks for corticosteroids to a period
of three weeks, without any certainty if the duration of this
period would be long enough. The lack of difference between
the sham and real acupuncture found at the end of this
study may be accounted for by ineffectiveness of the washout
period.
Due to the duration of the study period, which lasted
longer than expected (more than 4 years), we experienced a
considerable loss of volunteers who quit the study for several
reasons, as listed in Table 6. Although alarming, this loss is
expected in clinical trials lasting for long periods of time
(16,17). This loss of subjects is possibly the main weakness of
our study and prevented us from drawing convincing
conclusions about the contribution of acupuncture to asthma
treatment.
As this study took a long time to be completed (more than
4 years), we could not perform good seasonality control,
given periods of asthma exacerbation, with use of inhaled
glucocorticoids and both long- and short-acting b-agonists.
Although a period of washout was established every time
rescue medications were required, we could not be certain
about distinguishing both the acupuncture (either real or
sham) and rescue medication effects for the patients; this fact
certainly impaired the strength of our study.
Thus, the results showing no difference in NOmeasurements
and spirometry could be accounted for by poor seasonality
control, rescue medication use and an ineffective washout
period. Additionally, due to the heavy use of rescue medica-
tions, including inhaled glucocorticoids, we expected that the
inflammatory process (expressed in NO measurements) would
show differences between the pre-treatment group and both the
acupuncture and sham groups, although this was not observed.
This finding led us to think that perhaps most asthma patients
with controlled symptoms have silent, chronic airway inflam-
mation. In contrast, we observed a decrease in eosinophils and
neutrophils, especially in Group B, after the second interven-
tion (real acupuncture), which may point to the inflammation-
reducing effects of acupuncture. Moreover, there was an
increase in the macrophage count after real acupuncture in
Group B, suggesting a positive modulatory effect of real
acupuncture on increasing the macrophage count, which is
important in the atopic allergy process (16).
Other results of note include the improvement of peak
flow in Group B after the real acupuncture intervention; this
Table 2 - Difference in total eosinophil, neutrophil and macrophage counts in Group B between the inclusion period and after the
second intervention (real acupuncture).
White Cells N Mean Standard Deviation Standard Error of Mean
Eosinophils
Period of inclusion 46 10.97 20.29 2.99
After real acupuncture 46 5.21 13.16 1.94
Difference 46 5.761 18.01 2.66
Neutrophils
Period of inclusion 46 49.26 28.05 4.14
After real acupuncture 46 38.71 22.91 3.38
Difference 46 10.552 34.96 5.15
Macrophages
Period of inclusion 46 37.39 25.94 3.82
After real acupuncture 46 54.04 25.93 3.82
Difference 46 -16.653 31.17 4.60
1 - 95% CI for mean difference: (0.41; 11.11); p=0.035
2 - 95% CI for mean difference: (0.17; 20.93); p=0.047
3 - 95% CI for mean difference: (-25.91; -7.39); p=0.001
Table 3 - Daily self-report symptom scale in both Groups A and B after real acupuncture or sham interventions compared to the
inclusion period parameters.
GROUPS AND EXPOSURES
Group A - after real acupuncture Group A - after sham acupuncture
Symptoms Median Wilcoxon Test p Median Wilcoxon Test p
Coughing -0.05000 89.0 0.140 -0.1250 61.0 0.007
Wheezing -0.07250 129.5 0.096 -0.09000 101.5 0.037
Dyspnea -0.1100 127.0 0.052 -0.1925 45.0 0.000
Nocturnal awakening -0.01500 118.5 0.376 -0.05500 90.5 0.092
-2 Agonist spray use -0.07000 113.5 0.043 -0.1950 4.5 0.000
Group B - after sham acupuncture Group B - after real acupuncture
Median Wilcoxon Test p Median Wilcoxon Test p
Coughing -0.04500 200.0 0.037* -0.06000 189.0 0.040*
Wheezing -0.09000 186.5 0.013* -0.1150 185.0 0.012*
Dyspnea -0.08000 254.5 0.014* -0.1500 126.5 0.000*
Nocturnal awakening -0.01500 244.5 0.369 -0.04500 123.0 0.009*
-2 Agonist spray use 0.000000000 320.0 0.844 -0.01500 246.0 0.383
667
CLINICS 2015;70(10):663-669 Crossover acupuncture clinical trial on asthma
Pai HJ et al.
fact again points to the possible inflammation-reducing effect
of acupuncture.
We had difficulty establishing the sham points as a ‘‘true
placebo’’. Classically, sham points are defined as distant
points and may or may not technically have any therapeutic
effects when stimulated (12,17). However, there remains no
consensus about establishing sham points and there are
studies suggesting that sham points could have some
minimal therapeutic effects because any aching point on
the skin could serve as an acupuncture point (12,17).
Therefore, we could not distinguish significant effects between
treatment (acupuncture points) and placebo (sham points),
particularly in the symptoms and quality of life evaluation,
which led us to conclude that sham acupuncture may have
therapeutic, yet minimal effects. We selected many acupoints
in distant meridians that could have an influence on asthma
control, but we could not assure that these points really had
no effect on asthma. This fact could have contributed to the
lack of difference in the endpoints between the real and sham
acupuncture in the subjective fields of measurements (symp-
toms and quality of life). This limitation could also explain the
difference in effectiveness between the real acupuncture points
and the sham points during nocturnal awakening, the
decrease in use of rescue medication and the quality of life
Table 4 - Evaluation of the Questionnaire of Quality of Life in Asthma (QQLA) domains before (inclusion period) and after both the
real and sham interventions.
GROUPS AND EXPOSURES
Group A - after real acupuncture Group A - after sham acupuncture
Domains in QQLA-UNIFESP Median Wilcoxon Test p Median Wilcoxon Test p
Physical limitation -0.0833 74.0 0.006* -0.0450 144.5 0.117
Symptom frequency and severity -0.0898 71.0 0.001* -0.0833 74.5 0.001*
Adherence to treatment -0.0417 71.0 0.043* -0.0416 68.0 0.173
Socio-economic aspects -0.0208 80.0 0.080 0.0000 61.5 0.306
Socio-professional aspects -0.0179 75.5 0.059 0.0000 124.0 0.681
Psychosocial aspects -0.0156 95.0 0.314 0.0000 164.5 0.968
Social aspects -0.0518 56.5 0.00* -0.0406 110.5 0.021*
Group B - after sham acupuncture Group B - after real acupuncture
Median Wilcoxon Test p Median Wilcoxon Test p
Physical limitation -0.0333 284.0 0.212 -0.1167 181.5 0.001*
Symptom frequency and severity -0.0448 331.5 0.089 -0.0449 266.5 0.086
Adherence to treatment 0.0000 268.0 0.620 0.0000 366.0 0.833
Socio-economic aspects -0.0416 156.5 0.010* -0.0624 141.5 0.002*
Socio-professional aspects -0.0000 242.5 0.503 -0.0357 67.5 0.001*
Psychosocial aspects -0.0156 127.5 0.032* -0.0234 150.5 0.057
Social aspects -0.0264 277.0 0.018* -0.0508 231.0 0.004*
*po0.05
Table 5 - Evaluation of the SF-36 domains before (inclusion period) and after both the real and sham interventions.
GROUPS AND EXPOSURES
Group A - after real acupuncture Group A - after sham acupuncture
Domains in SF-36 Median Wilcoxon Test p Median Wilcoxon Test p
Functional capacity 7.50 252.0 0.004* 7.50 252.5 0.016*
Physical aspects 25.00 187.5 0.002* 25.00 199.0 0.004*
Pain 5.00 163.0 0.242 0.00 163.5 0.447
General health status 7.50 224.0 0.000* 7.50 259.0 0.010*
Vitality 7.50 268.5 0.019* 10.00 283.0 0.025*
Social aspects 6.25 169.5 0.168 6.25 235.5 0.131
Emotional aspects 0.00 82.0 0.485 0.00 90.5 0.255
Mental health 2.00 220.0 0.464 4.000 243.0 0.368
Group B - after sham acupuncture Group B - after real acupuncture
Median Wilcoxon Test p Median Wilcoxon Test p
Functional capacity 7.50 501.5 0.002* 10.00 625.5 0.001*
Physical aspects 12.50 265.5 0.023* 25.00 344.0 0.001*
Pain 0.00 270.5 0.666 5.00 324.5 0.021*
General health status 5.00 441.0 0.014* 10.00 570.5 0.000*
Vitality 5.00 473.5 0.028 10.00 543.5 0.001
Social aspects 6.25 351.0 0.211 12.50 389.5 0.006
Emotional aspects 0.00 263.0 0.175 16.67 284.0 0.067
Mental health -2.00 313.5 0.765 4.00 506.5 0.049*
*po0.05
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questionnaire. Thus, our results support the concept that sham
acupuncture is not possible, only acupuncture delivering
minimal effects (16).
The results of our study appear to suggest that acupuncture
does play an effective role in airway inflammation because
positive results were found in peak flow measurements and
decreases in the eosinophil and neutrophil counts in the
induced sputum and the increase in macrophages. These
findings showed a positive modulating effect on the immune
system, although no effects on spirometry or exhaled NO
measurement were found. In contrast, in terms of symptoms,
acupuncture (together with known medications) may offer
better symptom control and a better quality of life.
However, the number of volunteers who quit this study
may have compromised the measurement of the real effect of
acupuncture, prohibiting us from making a more positive
assumption about the effect of acupuncture. The lack of a
significant difference between the sham and real acupunc-
ture treatments also prevented us from deducing the
effectiveness of real acupuncture. However, sham acupunc-
ture may not be considered an effective placebo as it showed
an effect in this study.
Based on the points discussed above, we believe that the
crossover study design does not appear to be appropriate for
the evaluation of the effect of acupuncture, particularly
because we did not establish a reliable washout period and
sham acupuncture showed effects on asthma control.
Further studies are required to better understand the effects
of acupuncture in asthma, perhaps using other type of devices -
such as a needle that does not penetrate the skin but gives the
sensation of being pricked - to better fit the condition of sham
acupuncture points. In addition, the crossover design may not
be appropriate for the evaluation of acupuncture effects.
Acupuncture, together with other medications (like b-agonists,
regardless of whether they are short- or long-acting, leukotriene
modifiers or inhaled glucocorticoids), may have a positive effect
on symptom control and improvements in quality of life, in
addition to possible effects on the control of chronic airway
inflammation. However, due to several reasons, including a
significant number of volunteers who quit before the end of the
study protocol, we cannot guarantee these effects of acupuncture
on asthma.
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Robbed while undergoing study 1 0.9
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